FAO Calls For Action Amid Foot-And-Mouth Disease Outbreaks

5 May 2025
FMD is a highly contagious viral disease affecting cloven-hoofed animals, including cattle, pigs, sheep, goats, and various wild species.
Europe is currently facing its worst outbreak so far this century at the same time as an exotic viral strain has been introduced in Iraq and other countries in the Near East.
Concern for potential spread
' FAO is recommending urgent biosecurity measures and enhanced surveillance following the recent detection of foot-and-mouth disease (FMD) serotype SAT1 in Iraq and Bahrain,' the agency said in analert.
'This serotype is exotic to the Near East and West Eurasia regions,' the agency continued – meaning the strain is not normally found there – which raises 'serious concerns' about its potential spread.
FMD is typically characterized by fever and blisters in the mouth and on the feet of affected livestock, accompanied by lameness. Although few adult animals succumb to disease, young ones may die from sudden heart failure.
The virus spreads rapidly and can affect large numbers of animals, especially in countries or regions that are usually free of the disease or do not regularly use vaccination.
Although FMD is not a public health threat, it severely impacts animal health and welfare, food security and incomes by reducing agricultural productivity, including through decreased milk and meat yields.
The economic impact is also substantial, with global direct production losses and vaccination costs in endemic regions estimated to be $21 billion annually. FAO noted that the true economic burden is likely much higher when disruptions to both international and local trade are taken into consideration.
A major outbreak in the United Kingdom in 2001 led to the culling of more than six million animals and cost the economy billions, devastating the livestock industry and tourism. A series of new measures in response have reportedly reduced the risk and improved resilience, including local and national contingency plans for outbreaks.
Outbreaks and response
The FMD virus was recently detected in parts of Europe normally free of the disease and the continent is now experiencing its worst outbreak since 2001.
Germany detected an outbreak this past January but has since been declared FMD-free, however subsequent outbreaks in Hungary and Slovakia have persisted.
In response, the UK recently announced that it has banned imports of meat or dairy products from European countries where the virus has been detected, as well as Austria due to the outbreak in neighbouring Hungary.
FMD is endemic in the Near East, but the recent upsurge is due to an exotic serotype likely introduced from East Africa. Cases have been reported in Bahrain, Iraq and Kuwait, although other countries are at high risk.
Many strains of the FMD virus continue to circulate in different parts of the world, and the recent outbreaks in both Europe and the Near East highlight the ongoing risk the disease poses to livelihoods, food security and safe trade, said FAO.
Raising awareness
While all governments are urged to be vigilant, the agency said affected and high-risk countries should consider awareness-raising measures among farmers and communities to protect livestock.
Other recommendations include biosecurity measures such as separating sick animals from other livestock and having them examined by professionals, alongside checking vaccination records and verifying FMD contingency plans.
FAO said that by implementing these measures, countries can significantly reduce risks.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Techday NZ

3 days ago

• Techday NZ

Major healthcare providers leave email systems open to phishing risk

More than a third of the world's largest healthcare providers are yet to implement essential email security measures against phishing and spoofing, according to research conducted by EasyDMARC. The report analysed the adoption of DMARC, an email authentication protocol, across 4,100 prominent hospitals and clinics in both the United States and Europe, including the 100 highest-ranked healthcare organisations worldwide. The research revealed that while the proportion of top providers using DMARC increased marginally from 62% in 2024 to 65% in 2025, a substantial 35% still operate without DMARC protection altogether. Of those that have put DMARC in place, the study found that nearly half are not fully utilising its protective capabilities. Just 18% of the top 100 global providers have enforced DMARC to actively block suspicious emails, whilst 48% are using the weakest setting-known as 'p=none'-which merely monitors email activity and does not prevent fraudulent messages from reaching inboxes. Ongoing cyber threats The findings come against a backdrop of significant cyberattacks targeting the healthcare sector in recent years. This includes a notable breach at the UK's National Health Service (NHS) in 2024, where almost 400GB of patient data was illicitly obtained, as well as disruptions experienced by Yale New Haven Health in Connecticut. The report highlights that the sensitive nature of healthcare data and the sector's vital societal role make it an attractive target for cybercriminals. Healthcare organisations, which are heavily reliant on digital communication and critical infrastructure, are especially susceptible to cyber threats such as phishing attacks. Such incidents not only threaten financial loss but can also impact patient safety and healthcare delivery. DMARC functions by verifying whether incoming emails originate from approved sources, allowing organisations to block potentially fraudulent emails before they reach users. Full enforcement requires setting DMARC to 'p=reject', which rejects unverified emails outright rather than simply monitoring them. Regional differences in protection EasyDMARC's analysis of 2,000 of the largest European healthcare providers indicated that only 48% have DMARC implemented, and of those, over half have the setting at 'p=none'. This approach fails to block harmful messages, leaving significant vulnerabilities. In the United States, DMARC adoption reaches 55%, but nearly 40% of these providers also operate with the weakest monitoring-only policy. The research indicates that, despite an increase in awareness of email security, many healthcare providers remain exposed and have not moved towards policies that fully block phishing attempts. With over 90% of all cyberattacks said to originate via email phishing, the lack of comprehensive DMARC enforcement is highlighted as a substantial and ongoing risk. Industry-wide changes in policy from major email providers, including Google, Yahoo, and Microsoft, have made it mandatory for bulk email senders to enforce DMARC, reflecting the protocol's place as an industry standard. Microsoft's requirements came into force in early May. Call for stricter enforcement Gerasim Hovhannisyan, CEO of EasyDMARC said: "The healthcare sector is under constant pressure to protect patients, keep services running, and manage sensitive data, but too many organisations are still stopping short of full protection. DMARC only works when it's configured properly and enforced, and that means setting it to 'p=reject'. Anything less leaves inboxes open to impersonation and phishing attacks. For healthcare providers, the risk isn't just financial; it's operational and deeply human. Every unprotected email domain is another opportunity for attackers to disrupt care and put lives at risk." Data from the report also breaks down DMARC deployment within each region. In Europe, 955 of the 2,000 largest healthcare domains have valid DMARC records, but only 241 are set to 'p=reject' and 229 to 'p=quarantine', with the remainder on monitoring only. In the United States, 1,103 of 2,000 have DMARC records, 170 set to 'p=reject', and 501 to 'p=quarantine'. For the top 100 global providers, 65 domains have DMARC, with just 12 set to enforcement and 22 to quarantine. Healthcare providers are being encouraged by security experts to review their DMARC configurations and move toward full enforcement settings to better safeguard sensitive information and maintain the continuity of essential services in the face of increasingly sophisticated cyber threats.

1News

3 days ago

• 1News

Artificial solar eclipses created by two European satellites

A pair of European satellites have created the first artificial solar eclipses by flying in precise and fancy formation, providing hours of on-demand totality for scientists. The European Space Agency released the eclipse pictures at the Paris Air Show yesterday. Launched late last year, the orbiting duo have churned out simulated solar eclipses since March while zooming tens of thousands of kilometres above Earth. Flying 150 metres apart, one satellite blocks the sun like the moon does during a natural total solar eclipse as the other aims its telescope at the corona, the sun's outer atmosphere that forms a crown or halo of light. It's an intricate, prolonged dance requiring extreme precision by the cube-shaped spacecraft, less than 1.5 metres in size. Their flying accuracy needs to be within a mere millimeter, the thickness of a fingernail. This meticulous positioning is achieved autonomously through GPS navigation, star trackers, lasers and radio links. Dubbed Proba-3, the US$210 million (NZ$346.03 million) mission has generated 10 successful solar eclipses so far during the ongoing checkout phase. The longest eclipse lasted five hours, said the Royal Observatory of Belgium's Andrei Zhukov, the lead scientist for the orbiting corona-observing telescope. He and his team are aiming for a wondrous six hours of totality per eclipse once scientific observations begin in July. ADVERTISEMENT Scientists already are thrilled by the preliminary results that show the corona without the need for any special image processing, said Zhukov. "We almost couldn't believe our eyes,' Zhukov said in an email. 'This was the first try, and it worked. It was so incredible.' Two spacecraft of the Proba-3 mission aligning to create an eclipse to capture a coronagraph in space. (Source: Associated Press) Zhukov anticipates an average of two solar eclipses per week being produced for a total of nearly 200 during the two-year mission, yielding more than 1000 hours of totality. That will be a scientific bonanza since full solar eclipses produce just a few minutes of totality when the moon lines up perfectly between Earth and the sun — on average just once every 18 months. The sun continues to mystify scientists, especially its corona, which is hotter than the solar surface. Coronal mass ejections result in billions of tons of plasma and magnetic fields being hurled out into space. Geomagnetic storms can result, disrupting power and communication while lighting up the night sky with auroras in unexpected locales. While previous satellites have generated imitation solar eclipses — including the European Space Agency and NASA's Solar Orbiter and Soho observatory — the sun-blocking disk was always on the same spacecraft as the corona-observing telescope. What makes this mission unique, Zhukov said, is that the sun-shrouding disk and telescope are on two different satellites and therefore far apart. The distance between these two satellites will give scientists a better look at the part of the corona closest to the limb of the sun. ADVERTISEMENT "We are extremely satisfied by the quality of these images, and again this is really thanks to formation flying' with unprecedented accuracy, ESA's mission manager Damien Galano said from the Paris Air Show.

Scoop

5 days ago

• Scoop

EPA Faces High Court Challenge Over Glyphosate

The Environmental Law Initiative is challenging the Environmental Protection Authority (EPA) in the High Court today over its decision that there were no grounds to reassess the herbicide glyphosate, along with more than 90 glyphosate-based formulations currently approved for use in Aotearoa. Despite glyphosate being used in Aotearoa for over 50 years, the EPA has never conducted a full risk assessment of the chemical. 'The EPA should have a full understanding of the effects of glyphosate to ensure Aotearoa's regulatory settings are fit for purpose,' says Tess Upperton, Senior Legal Advisor at the Environmental Law Initiative (ELI). 'Glyphosate is the most widely used herbicide in Aotearoa. It's sprayed on our food, roadsides, public spaces, around playgrounds, and in backyards.' 'Given its widespread use, it's alarming that we've never undertaken a comprehensive risk assessment to understand the impacts on our people and the environment,' says Upperton. In addition to glyphosate itself, the EPA has never done a full risk assessment for glyphosate-based formulations that have been 'grandfathered in' under current regulations—many of which are significantly more toxic than glyphosate alone. These formulations often include additional ingredients that amplify glyphosate's toxicity, including surfactants such as POEA (polyethoxylated tallow amine), classified as a "forever chemical" due to its persistence in the environment. 'These formulations should be undergoing risk assessments that consider their effects in Aotearoa—but they're not. And that's deeply concerning, particularly as their approvals do not expire,' says Upperton. Over recent decades, scientific evidence of glyphosate's harm to human health, biodiversity, and ecosystems has grown. Many regulators overseas have responded by tightening restrictions on glyphosate use. In contrast, the regulatory approach in Aotearoa has remained largely unchanged. 'While other countries have moved to protect public health and the environment, Aotearoa remains one of the most permissive regulators of glyphosate globally,' says Upperton. That includes allowing glyphosate use in settings where it's banned elsewhere—for instance, as a pre-harvest desiccant on crops, a practice prohibited in the European Union. Several European countries have also banned the domestic sale of glyphosate, restricting its use to regulated agricultural and commercial settings. Meanwhile, in New Zealand, the Ministry for Primary Industries has recently proposed increasing the Maximum Residue Levels (MRLs) for glyphosate on certain crops—by up to 100 times. 'This legal challenge is not about banning glyphosate,' Upperton clarifies. 'It's about the EPA making informed decisions about how these chemicals are regulated in Aotearoa.' About the Case In 2023, the Environmental Law Initiative formally requested for the EPA to determine whether there were grounds for reassessing glyphosate and glyphosate-based substances under the Hazardous Substances and New Organisms Act. The application was based on significant new scientific information that has emerged since glyphosate was first introduced in Aotearoa in the 1970s. In July 2024, the EPA declined the request, stating it did not believe sufficient grounds for reassessment existed. ELI will challenge that decision in the Wellington High Court on 16 and 17 June 2025.